GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Net Change in Cash

NuCana (NuCana) Net Change in Cash : $-30.47 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is NuCana Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

NuCana's Net Change in Cash for the three months ended in Dec. 2023 was $-0.73 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $-30.47 Mil.

NuCana Net Change in Cash Historical Data

The historical data trend for NuCana's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Net Change in Cash Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only -32.78 47.57 -36.03 -22.35 -31.25

NuCana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.77 -13.24 -8.03 -8.47 -0.73

NuCana Net Change in Cash Calculation

NuCana's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-33.467+3.656+-0.067+-1.371
=-31.25

NuCana's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.097+0.067+-0.054+-0.647
=-0.73

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuCana Net Change in Cash Related Terms

Thank you for viewing the detailed overview of NuCana's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana (NuCana) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Net Change in Cash
Comparable Companies
ABIO CADL PTN SEEL MAIA NRXP ORGS CRIS ALGS VIRX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N04A:Germany
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
Website
https://www.nucana.com
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.